Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Horizon Therapeutics (HZNP)

Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Horizon Therapeutics 70 St. Stephen's Green Dublin L2 D02 E2X4 IRL

www.horizontherapeutics.com P: 011-353-1772

Description:

Horizon Therapeutics plc is a biopharmaceutical focused on making drugs in arthritis, pain, inflammatory and orphan diseases areas.

Key Statistics

Overview:

Market Capitalization, $K 26,632,118
Enterprise Value, $K 26,837,368
Shares Outstanding, K 228,995
Annual Sales, $ 3,629 M
Annual Net Income, $ 521,480 K
Last Quarter Sales, $ 944,960 K
Last Quarter Net Income, $ 127,070 K
EBIT, $ 513,370 K
EBITDA, $ 967,850 K
60-Month Beta 1.03
% of Insider Shareholders 2.20%
% of Institutional Shareholders 80.37%
Float, K 223,957
% Float 97.80%
Short Volume Ratio 0.28

Growth:

1-Year Return 73.45%
3-Year Return 37.81%
5-Year Return 536.56%
5-Year Revenue Growth 243.58%
5-Year Earnings Growth 311.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.20 on 08/08/23
Next Earnings Date 11/01/23
Earnings Per Share ttm 4.49
EPS Growth vs. Prev Qtr 44.58%
EPS Growth vs. Prev Year 12.15%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HZNP Ratios

Ratio
Price/Earnings ttm 25.89
Price/Earnings forward 27.74
Price/Earnings to Growth 3.96
Return-on-Equity % 20.46%
Return-on-Assets % 11.52%
Profit Margin % 14.37%
Debt/Equity 0.48
Price/Sales 7.34
Price/Cash Flow 16.49
Price/Book 5.01
Book Value/Share 23.20
Interest Coverage 7.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar